TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Malaysia, Singapore begin purchase of Merck's COVID-19 pill
Molnupiravir, which would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown.
Change Size
This handout photo obtained May 26, 2021, courtesy of Pharmaceutical company Merck shows capsules of the experimental antiviral drug Molnupiravir. Merck said on October 1, 2021, it will seek authorization in the US for molnupiravir for Covid-19, after the pill showed (AFP/Handout)
M
alaysia has struck a deal with US drugmaker Merck & Co to buy 150,000 courses of its experimental antiviral pill, the health ministry said on Thursday, joining other Asian countries in a rush to secure supplies.
Molnupiravir, which would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown.
The data sparked large demand for the drug in Asia, with South Korea, Singapore and Australia announcing similar deals to buy the Merck pill this week. Taiwan and Thailand are also in talks to buy it.
Malaysia's Health Minister Khairy Jamaluddin said the government signed a letter of undertaking for the purchase on Thursday.
"This decision was made as we prepare to transition into an endemic phase, where we can co-exist with the virus by adding new innovative treatments as 'weapons' to fight COVID-19, apart from vaccinations and other public health measures," Khairy said in a statement.
Malaysia has recorded nearly 2.3 million COVID-19 infections, the third-highest in Southeast Asia, but has gradually lifted movement restrictions in recent weeks as the number of new cases declined amid a ramped-up vaccination programme.
About 64 percent of Malaysia's 32 million population are now fully vaccinated, including 88 percent of adults.
